We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.24B
| $2.41M | 0.01% |
206,174
-53,500
| -21% | -$610K |
|
|
GLQ
527
Clough Global Equity Fund
GLQ
$150M
| $2.41M | 0.01% |
155,737
-40,400
| -21% | -$614K |
|
|
HOT
528
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $2.41M | 0.01% |
29,822
+12,460
| +72% | +$980K |
|
529
US Bancorp
USB
$99.3B
| $2.39M | 0.01% |
55,287
-22,577
| -29% | -$942K |
|
|
SFR
530
DELISTED
Starwood Waypoint Homes
SFR
| $2.39M | 0.01% |
91,270
| – | – |
|
531
Northrop Grumman
NOC
$77.2B
| $2.37M | 0.01% |
19,824
+6
| +0% | +$725 |
|
|
TC
532
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
| $2.37M | 0.01% |
800,367
+742,182
| +1,276% | +$2.05M |
|
533
Dana Inc
DAN
$2.9B
| $2.37M | ﹤0.01% |
97,000
| – | – |
|
|
N
534
DELISTED
Netsuite Inc
N
| $2.35M | ﹤0.01% |
27,092
+2,850
| +12% | +$230K |
|
535
Bath & Body Works
BBWI
$4.01B
| $2.35M | ﹤0.01% |
+49,480
| New | +$2.27M |
|
536
Weyerhaeuser
WY
$17.5B
| $2.3M | ﹤0.01% |
69,496
-84,085
| -55% | -$2.54M |
|
537
Canadian Natural Resources
CNQ
$96B
| $2.29M | ﹤0.01% |
+103,427
| New | +$2.07M |
|
|
OUTR
538
DELISTED
OUTERWALL INC
OUTR
| $2.27M | ﹤0.01% |
38,315
+30
| +0.1% | +$2.03K |
|
|
LINE
539
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
| $2.26M | ﹤0.01% |
+70,000
| New | +$2.05M |
|
540
O'Reilly Automotive
ORLY
$75.2B
| $2.26M | ﹤0.01% |
225,120
-75
| -0% | -$740 |
|
541
Verisk Analytics
VRSK
$28.7B
| $2.25M | ﹤0.01% |
37,563
+31,125
| +483% | +$1.86M |
|
542
Jack in the Box
JACK
$319M
| $2.25M | ﹤0.01% |
37,572
+35
| +0.1% | +$2.01K |
|
543
Boston Properties
BXP
$11.8B
| $2.22M | ﹤0.01% |
18,809
+1,316
| +8% | +$155K |
|
|
EDR
544
DELISTED
Education Realty Trust Inc
EDR
| $2.22M | ﹤0.01% |
68,802
+30,134
| +78% | +$932K |
|
|
AFSI
545
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $2.19M | ﹤0.01% |
+105,032
| New | +$2.16M |
|
|
HOS
546
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $2.18M | ﹤0.01% |
46,443
| – | – |
|
547
Icon
ICLR
$13.6B
| $2.1M | ﹤0.01% |
44,685
+40,468
| +960% | +$1.75M |
|
548
United Therapeutics
UTHR
$25.8B
| $2.1M | ﹤0.01% |
23,782
-32,549
| -58% | -$3.13M |
|
549
Starwood Property Trust
STWD
$6.16B
| $2.07M | ﹤0.01% |
+87,192
| New | +$2.08M |
|
|
AGN
550
DELISTED
Allergan Inc
AGN
| $2.04M | ﹤0.01% |
12,048
-2,570
| -18% | -$400K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.